Episode Details

Back to Episodes

Kenvue Plunges 13%: From Baby Powder Lawsuits to Tylenol Scares

Season 1 Episode 44 Published 1 year ago
Description

Kenvue’s nightmare just got worse — the stock’s down 13% as thousands sue over baby powder in the U.K. and the White House eyes a review linking Tylenol to autism risk. With lawsuits piling up, an interim CEO, layoffs, and activist investors circling, the once “safe” consumer-health giant looks anything but steady.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us